Alyce S. Adams

Alyce Adams, Stanford Health Policy Profile 2022

Alyce S. Adams , PhD, MPP

  • Stanford Medicine Innovation Professor
  • Professor, Epidemiology and Population Health
  • Professor, Health Policy
  • Professor, Pediatrics (by courtesy)

Biography

Alyce Adams is a Professor of Health Policy and of Epidemiology and Population Health in the Stanford School of Medicine; Associate Chair, Partnership and Community Engagement for the Department of Health Policy; and Associate Director for Health Equity and Community Engagement in the Stanford Cancer Institute. Focusing on racial and socioeconomic disparities in chronic disease treatment outcomes, Dr. Adams' interdisciplinary research seeks to evaluate the impact of changes in drug coverage policy on access to essential medications, understand the drivers of disparities in treatment adherence among insured populations, and test strategies for maximizing the benefits of treatment outcomes while minimizing harms through informed decision-making. Prior to joining Stanford School of Medicine, Dr. Adams was Associate Director for Health Care Delivery and Policy and a Research Scientist at the Kaiser Permanente Division of Research, as well as a Professor at the Bernard J. Tyson Kaiser Permanente School of Medicine. From 2000 to 2008, she was an Assistant Professor in the Department of Population Medicine (formerly Ambulatory Care and Prevention) at Harvard Medical School and Harvard Pilgrim Health care. She received her PhD in Health Policy and an MPP in Social Policy from Harvard University. She is Vice Chair of the Board of Directors for AcademyHealth and a former recipient of the John M. Eisenberg Excellence in Mentoring Award from Agency for Healthcare Research and Quality and an invited lecturer on racial disparities in health care in the 2014/2015 National Institute of Mental Health Director’s Innovation Speaker Series.

In The News

Stanford Health Policy's Alyce Adams addresses AI conference
News

Legal Risks and Rewards of Artificial Intelligence in Health Care

Stanford Health Policy researchers address issues of liability risk and the ethical use of AI in health care, making the case for tools that address liability and risk—while making patient safety and concerns a priority.
Legal Risks and Rewards of Artificial Intelligence in Health Care
An artistic illustration of human kidneys
News

Balancing Efficiency and Equity in Screening for Chronic Kidney Disease

More than one in seven adults in the United States are believed to have chronic kidney disease, with the burden disproportionately impacting Black and Hispanic adults. A new Stanford study suggests a population-wide CKD screening could reduce these disparities.
Balancing Efficiency and Equity in Screening for Chronic Kidney Disease
Illustration of (W)Health Equity
News

SHP Faculty Contribute to New NASEM Report on Health-Care Inequities

The National Academies of Sciences, Engineering, and Medicine updates its 20-year-old report on inequities in the U.S. health-care system, with expert advise from Stanford Health Policy researchers.
SHP Faculty Contribute to New NASEM Report on Health-Care Inequities